NYSE · Financial Statements
AbbVie Inc. (ABBV) Financial Statements
$285.42
NYSE: ABBV
Market Cap $504.37B
Overview Financials Dividend
AbbVie Inc. most recently reported annual revenue of $61.2B, net profit of $4.2B. Revenue grew at an average annual rate of 6.0% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $56.2B $58.1B $54.3B $56.3B $61.2B Operating Profit $17.9B $18.1B $12.8B $9.1B $20.1B Net Profit $11.5B $11.8B $4.9B $4.3B $4.2B EPS $6.45 $6.63 $2.72 $2.39 $2.37 Op Margin 31.9% 31.2% 23.5% 16.2% 32.9%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $146.5B $138.8B $134.7B $135.2B $134.0B Total Liabilities $131.1B $121.5B $124.3B $131.8B $137.2B Cash $9.7B $9.2B $12.8B $5.5B $5.2B Borrowings $77.6B $64.2B $60.1B $67.8B $69.1B
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $22.8B $24.9B $22.8B $18.8B $19.0B Investing Cash Flow $-3.1B $-1.3B $-2.8B $-21.8B $-7.9B Financing Cash Flow $-1.4B $-2.3B $-2.5B $-1.5B $-912.0M Net Cash Flow $1.3B $-545.0M $3.6B $-7.3B $-295.0M Free Cash Flow $22.0B $24.2B $22.1B $17.8B $17.8B
Valuation & Return Ratios
Metric Value PEG Ratio 1.17 EV / EBITDA 26.68 FCF Yield 3.64% Quick Ratio 0.69 Interest Coverage 6.47 Return 1Y 29.03% Return 3Y 112.68% Return 5Y 203.27%
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .